https://pipelinereview.com/GEMoaB-Announces-First-Patient-Dosed-With-the-Affinity-Tailored-T-Cell-adaptor-GEM3PSCA-in-a-Phase-I-Study-in-PSCA-positive-Late-Stage-Solid-Tumors/
GEMoaB Announces First Patient Dosed With the Affinity-Tailored T-Cell-adaptor GEM3PSCA in a Phase I Study in PSCA-positive Late-Stage Solid Tumors